Narrow your search

Library

EhB (1)

KU Leuven (1)

LUCA School of Arts (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLL (1)

ULB (1)

ULiège (1)

VDIC (1)

More...

Resource type

book (2)


Language

English (2)


Year
From To Submit

2010 (2)

Listing 1 - 2 of 2
Sort by

Book
Angiogenesis inhibition
Authors: --- ---
ISBN: 354078280X 9786612828140 3540782818 1282828142 Year: 2010 Publisher: Heidelberg : Springer,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.


Book
Angiogenesis Inhibition
Authors: --- --- ---
ISBN: 9783540782803 9783540782810 Year: 2010 Publisher: Berlin Heidelberg Springer Berlin Heidelberg

Loading...
Export citation

Choose an application

Bookmark

Abstract

Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.

Keywords

Listing 1 - 2 of 2
Sort by